Clinical Trial Update: Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone Metastases [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial of genistein in patients undergoing external-beam radiation therapy for bone metastases was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Kidney Cancer
• Lung Cancer
• Melanoma
• Prostate Cancer

Drugs mentioned

• Genistein (genistein)

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Breast Cancer, Kidney Cancer | Phase 1, Phase 2 | Status: WITHDRAWN